After 5 weeks of taking 300 mg of lithium daily, a 76-year-old woman with lurasidone-induced tardive dyskinesia from treatment for Bipolar II Disorder experienced reduced impact, intensity, and ...

Lithium (Li⁺) remains a foundational treatment in psychiatry, particularly for bipolar disorder, manic episodes, and suicide prevention in major depressive ...

The randomized clinical trial is recruiting 50 adults ages 18 to 80 with long COVID to participate. For more information on the trial, call 716-829-5454. The placebo-controlled trial is examining the ...

Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...

Lithium is the lightest metal—indeed, it can float on water—with a variety of uses in the modern world, including as the negative electrode in lithium batteries, a coolant inside nuclear power plants, ...

Initial trials of low-dose lithium failed to improve long COVID symptoms, but new findings suggest higher doses could offer hope for patients suffering from fatigue and cognitive impairment. Study: ...

Lithium was associated with a higher risk of thyroid and kidney dysfunction versus non-lithium treatments in bipolar disorder patients. Associations were dose-dependent and serum level cutoffs for ...

Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...